Sharemaestro company-news research for Ultragenyx Pharmaceutical Inc. (R2AR34), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
SAO
Brazil
Insufficient evidence
Company news sentiment
R2AR34 news sentiment
Ultragenyx Pharmaceutical Inc.
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score50Neutral is 50
No directional headline signal
0/100 evidence confidence
0% direct company focus
2 current stories across 0 publishers
Current company news
No current company-news score
No company-specific headline in the last 30 days currently passes the date and relevance checks. The displayed 50 means no score, not a neutral view.
Observed headline tone50/100
→
Published 30-day score50/100
Latest source headline
Ultragenyx Pharmaceutical Number of Employees 2026 | Employee Count & Headcount Data
Revelio Labs · 01 Aug 2026 08:17 · Source lookup
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
Available information
2 current stories are mapped specifically to R2AR34.
Why there is no score
The stories agree, but freshness-weighted evidence is only 0.000.
Confidence is 0/100, below the threshold for a firm score.
50/100
News scoreNo directional headline signal
0/100
Confidencethin evidence
0%/100
Company news2 company stories
100/100
Story agreement0/100 difference
News history
Daily score and story count over 30 days
27 Jul11 Aug25 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence0
0.0 after freshness weightingSource breadth0
0 independent publishersCompany relevance0
share tied directly to this companyFreshness1
recency-weighted evidenceAgreement100
how closely stories agreePublisher mix0
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
No sufficiently fresh, directly relevant company news is available for a price comparison.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
12 Jun17 Jul21 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
21 Aug 202650BRL 13.46+4.6%
14 Aug 202650BRL 12.87+0.0%
07 Aug 202650BRL 12.87+2.6%
31 Jul 202650BRL 12.54-21.4%
24 Jul 202650BRL 15.96+0.0%
Insufficient evidence
News subjects
What is shaping the score
Market update502 stories · 100%
Source mix
Where the evidence comes from
Revelio Labs501 stories · 50%
TradingView501 stories · 50%
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
20 Jul50 neutral25 Aug 11:03
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 25 Aug 11:03 | 50 | +0 | 0/100 (0) | 2 (-2) | Insufficient |
| 01 Aug 23:59 | 50 | +0 | 0/100 (0) | 4 (+1) | Insufficient |
| 30 Jul 23:59 | 50 | +0 | 0/100 (0) | 3 (+1) | Insufficient |
| 23 Jul 23:59 | 50 | +0 | 0/100 (0) | 2 (+1) | Insufficient |
| 20 Jul 23:59 | 50 | Start | 0/100 | 1 | Insufficient |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#1—Not directional
Revelio LabsDirect company coverageScored from headlineSource lookup
Ultragenyx Pharmaceutical Number of Employees 2026 | Employee Count & Headcount Data
- Published
- 01 Aug 2026 08:17
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 24.1d old
- Duplicates
- 1 consolidated
#2—Not directional
TradingViewDirect company coverageScored from headlineSource lookup
Ultragenyx Pharmaceutical Inc Shs Unsponsored Brazilian Depositary Receipt Repr 0.1 Sh
- Published
- 30 Jul 2026 02:52
- News subject
- Market update
- Why this score
- The headline reports news without a clear direction
- Company focus
- Main company · 100%
- How it is used
- Shown as company news · not used in the score
- Story strength
- Not directional
- 30-day weight
- None · 26.3d old
- Duplicates
- 1 consolidated
Earlier company news
R2AR34 news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 2 older R2AR34 headlines. Open one page at a time when you need them.
Open older archiveHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.